About the PCEC
The Prostate Conditions Education Council (PCEC), formally the Prostate Cancer Education Council, was founded in 1989 and is a non-profit 501-3c organization. A national organization committed to men’s health, PCEC is the nation’s leading resource for information on prostate health.
PCEC is dedicated to saving lives through awareness and the education of men, the people in their lives, as well as the medical community about prostate cancer prevalence, the importance of early detection, available treatment options and other men’s health issues. The Council – comprised of a consortium of leading physicians, health educators, scientists and prostate cancer advocates – aims to conduct nation wide screenings for men and perform research that will aid in the detection and treatment of prostate conditions. More information is available at www.prostateconditions.org.
As the founder and coordinator of the national Prostate Cancer Awareness Week (PCAW) Program, we have screened nearly 5,000,000 men across the country for the disease and have become one of the largest and most successful health screening projects in the world.
PCEC is not only the national leader in providing prostate cancer screenings for men in all stages of the disease; it is also the national leader in increasing awareness and education on prostate disease. Our education and awareness campaigns include a wide variety of forums and have expansive reach.
As the leading innovative organization, saving and improving the lives of men and their loved ones, we SET the PACEin early detection, research, education and awareness for prostate cancer and all prostate conditions.
- To reach men and the people in their lives to increase awareness of prostate cancer and its treatment options for all stages of the disease.
- To reach a variety of demographics including patients, caregivers and physicians with updated and current information on the disease.
- To provide access to free early detection for prostate cancer and other men’s health issues, including evaluation for advanced cancer patients.